124 related articles for article (PubMed ID: 35372457)
1. Evaluation of the Prognostic Value of CD56 (140 kDa Isoform) Expression in Breast Cancer Tissues: an Eight-Year Retrospective Study.
Niknam K; Safaei A; Ghaderi A
Iran Biomed J; 2022 May; 26(3):175-82. PubMed ID: 35372457
[TBL] [Abstract][Full Text] [Related]
2. Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma.
Serrero G; Hawkins DM; Yue B; Ioffe O; Bejarano P; Phillips JT; Head JF; Elliott RL; Tkaczuk KR; Godwin AK; Weaver J; Kim WE
Breast Cancer Res; 2012 Feb; 14(1):R26. PubMed ID: 22316048
[TBL] [Abstract][Full Text] [Related]
3. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic FOXP1 expression is correlated with ER and calpain II expression and predicts a poor outcome in breast cancer.
Yu BH; Li BZ; Zhou XY; Shi DR; Yang WT
Diagn Pathol; 2018 May; 13(1):36. PubMed ID: 29848352
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma.
Xiao M; Xu Q; Lou C; Qin Y; Ning X; Liu T; Zhao X; Jia S; Huang Y
Hum Pathol; 2017 Apr; 62():40-49. PubMed ID: 28087477
[TBL] [Abstract][Full Text] [Related]
6. [The comparison of characters between invasive micropapillary carcinoma and invasive ductal carcinoma not otherwise specified of the breast].
Hua B; Lu X; Xiao WZ; He SR; Wang Z
Zhonghua Wai Ke Za Zhi; 2017 Oct; 55(10):770-774. PubMed ID: 29050179
[No Abstract] [Full Text] [Related]
7. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis.
Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
Cancer Med; 2017 Dec; 6(12):2775-2786. PubMed ID: 29072365
[TBL] [Abstract][Full Text] [Related]
8. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
Zhao H
Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
[TBL] [Abstract][Full Text] [Related]
9. Is the tumor infiltrating natural killer cell (NK-TILs) count in infiltrating ductal carcinoma of breast prognostically significant?
Rathore AS; Goel MM; Makker A; Kumar S; Srivastava AN
Asian Pac J Cancer Prev; 2014; 15(8):3757-61. PubMed ID: 24870789
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling revealed MCM3 to be a better marker than Ki67 in prognosis of invasive ductal breast carcinoma patients.
Zhao Y; Wang Y; Zhu F; Zhang J; Ma X; Zhang D
Clin Exp Med; 2020 May; 20(2):249-259. PubMed ID: 31980982
[TBL] [Abstract][Full Text] [Related]
11. Runx2 Expression as a Potential Prognostic Marker in Invasive Ductal Breast Carcinoma.
El-Gendi SM; Mostafa MF
Pathol Oncol Res; 2016 Jul; 22(3):461-70. PubMed ID: 26597806
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.
Chen Y; Song J; Jiang Y; Yu C; Ma Z
Int J Clin Exp Pathol; 2015; 8(9):11287-95. PubMed ID: 26617852
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
[TBL] [Abstract][Full Text] [Related]
14. Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes.
Goh CW; Wu J; Ding S; Lin C; Chen X; Huang O; Chen W; Li Y; Shen K; Zhu L
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1877-1886. PubMed ID: 31089799
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Distribution Pattern of 21-Gene Recurrence Score between Mucinous Breast Cancer and Infiltrating Ductal Carcinoma in Chinese Population: A Retrospective Single-Center Study.
Wu J; Ding S; Lin L; Fei X; Lin C; Andriani L; Goh C; Huang J; Hong J; Gao W; Zhu S; Wang H; Huang O; Chen X; He J; Li Y; Shen K; Chen W; Zhu L
Cancer Res Treat; 2020 Jul; 52(3):671-679. PubMed ID: 32019280
[TBL] [Abstract][Full Text] [Related]
16. X-linked inhibitor of apoptosis positive nuclear labeling: a new independent prognostic biomarker of breast invasive ductal carcinoma.
Zhang Y; Zhu J; Tang Y; Li F; Zhou H; Peng B; Zhou C; Fu R
Diagn Pathol; 2011 Jun; 6():49. PubMed ID: 21645409
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic and Predictive Value of Thyroid Transcription Factor-1, CD56, P40 and Other Clinical Characteristics in Small Cell Lung Cancer Patients].
Wang X; Zhang Y; Hu M; Wang R; Liu L; Qian K; Li Y; Zhi X
Zhongguo Fei Ai Za Zhi; 2017 Aug; 20(8):522-527. PubMed ID: 28855032
[TBL] [Abstract][Full Text] [Related]
18. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
[TBL] [Abstract][Full Text] [Related]
19. Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.
Metzger-Filho O; Ferreira AR; Jeselsohn R; Barry WT; Dillon DA; Brock JE; Vaz-Luis I; Hughes ME; Winer EP; Lin NU
Oncologist; 2019 Jul; 24(7):e441-e449. PubMed ID: 30518616
[TBL] [Abstract][Full Text] [Related]
20. TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer.
Stürken C; Möbus V; Milde-Langosch K; Schmatloch S; Fasching PA; Rüschoff J; Stickeler E; Henke RP; Denkert C; Hanker L; Schem C; Vladimirova V; Karn T; Nekljudova V; Köhne CH; Marmé F; Schumacher U; Loibl S; Müller V
BMC Cancer; 2021 Aug; 21(1):920. PubMed ID: 34391399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
